Clincosm LogoSign in Get a demo

myeloid leukemia

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

Not yet recruiting
  • Breast Cancer
  • +9 more
  • Assessment tool IA3-CP with SDoH
  • Assessment tool IA3-CP without SDoH
  • (no location specified)
May 22, 2023

Frequency and Risk Factors of Acute Myeloid Leukemia

Not yet recruiting
  • Myeloid Leukemia
  • Bone marrow aspirite for diagnosis
  • (no location specified)
Mar 15, 2023

Chronic Health Conditions in Down Syndrome-Associated Acute

Not yet recruiting
  • Down Syndrome
  • +7 more
  • Neurological Assessments
  • +3 more
  • (no location specified)
Jan 18, 2023

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

Myeloid Leukemia Trial in Columbus, Houston (IMC-EB10)

Terminated
Has Results
  • Myeloid Leukemia
  • IMC-EB10
  • Columbus, Ohio
  • +1 more
Dec 20, 2022

Implantation ofAdvanced Practice Nurse in Complex Care Pathway

Not yet recruiting
  • Myeloid Leukemia
  • Interviews
  • (no location specified)
Jul 13, 2022

Describe Real World Use of Bosutinib inSingle Centre in Scotland

Completed
  • Myeloid Leukemia
  • Glasgow, United Kingdom
    eatson West of Scotland Cancer Centre
May 3, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)

Active, not recruiting
  • Hodgkin Lymphoma
  • +6 more
  • Intravenous (IV) and oral Vitamin C
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022

Acute Myeloid Leukemia, Myeloid Leukemia, Monocytic Leukemia Trial in Minneapolis (Daratumumab/rHuPH20, FT538, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 3, 2021

Acute Myeloid Leukemia, Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston (Biopsy, Biospecimen Collection,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Biopsy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 9, 2021

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Acute Myeloid Leukemia, Leukemia, Myeloid Leukemia Trial in Spain (cyclophosphamide, Fludarabine, NK cell infusion)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Barakaldo, Vizcaya, Spain
  • +5 more
Oct 1, 2020

Chronic Lymphocytic Leukemia, GVHD, Leukemia Trial run by the NHLBI (Blood cell transplantation)

Completed
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Blood cell transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

B-cell Acute Lymphoblastic Leukemia, Lymphoma, Myeloid Leukemia Trial in Zhengzhou (CAR-T cell immunotherapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +15 more
  • CAR-T cell immunotherapy
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Dec 10, 2019

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Plasma Cell Myeloma Trial in Madison (Behavioral techniques)

Completed
  • Hodgkin Lymphoma
  • +6 more
  • Behavioral techniques
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 13, 2019

Hodgkin's Lymphoma, Leukemia, Lymphoid Leukemia Trial in Madison (Behavioral techniques)

Completed
  • Hodgkin's Lymphoma
  • +6 more
  • Behavioral techniques
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 14, 2019

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Unknown status
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Sep 3, 2018

Myeloid Leukemia, Precursor Myeloid Tumors, Lymphoid Tumors Trial in Basel, Geneva, Zurich (Busulfan-Cyclophosphamide as

Completed
  • Myeloid Leukemia
  • +2 more
  • Busulfan-Cyclophosphamide as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation
  • Cyclophosphamide-Busulfan as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation
  • Basel, Switzerland
  • +2 more
Mar 1, 2018

Cancer, Hematologic Malignancies, Leukemia Trial in Stony Brook, Cleveland, Houston (Arm 1- Dose Escalation, Arm 2- Dose

Completed
  • Cancer
  • +3 more
  • Arm 1- Dose Escalation
  • Arm 2- Dose Expansion
  • Stony Brook, New York
  • +2 more
Nov 1, 2017

Myeloid Leukemia, MDS Trial in Marseille (blood samples, azacytidine)

Unknown status
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Marseille, France
    Assistance Publique - Hopitaux de Marseille
Jul 2, 2015

Myeloid Leukemia, Myelodysplastic Syndrome Trial in Dresden (5-Azacytidin)

Completed
  • Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Dresden, Saxony, Germany
    University hospital Dresden, department of medicine
Jul 8, 2011

Myeloid Leukemia Trial in Nürnberg (Prophylactic platelet transfusion, Therapeutic platelet transfusion)

Completed
  • Myeloid Leukemia
  • Prophylactic platelet transfusion
  • Therapeutic platelet transfusion
  • Nürnberg, Germany
    Klinikum Nürnberg Nord; Einheit für Knochenmarktransplantation;
May 18, 2011

Myeloid Leukemia Trial in Worldwide (AZD1152)

Completed
  • Myeloid Leukemia
  • New York, New York
  • +9 more
Dec 7, 2010